Evaluation of pharmacist-prescribed nirmatrelvir/ritonavir for patients with COVID-19
Nirmatrelvir/ritonavir was appropriately prescribed by pharmacists in most cases, demonstrating that pharmacists can support safe and effective use of nirmatrelvir/ritonavir for patients with complex comorbidities and medication regimens.
Authors
- Magnhild Rasmussen (ORCID: https://orcid.org/0000-0002-2277-8425)
- Amber Sowles
- Adriane N. Irwin (ORCID: https://orcid.org/0000-0002-2086-4493)
- Ralph A Yates
- Jason Srey
- Samantha Divan
Institutions
- Oregon State University (US)
- Salem Hospital (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1093/ajhp/zxaf061
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00